Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Tjeerd J Postma"'
Autor:
Linda Brom, H Roeline W Pasman, Guy A M Widdershoven, Maurice J D L van der Vorst, Jaap C Reijneveld, Tjeerd J Postma, Bregje D Onwuteaka-Philipsen
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100435 (2014)
PURPOSE: Patients are often encouraged to participate in treatment decision-making. Most studies on this subject focus on choosing between different curative treatment types. In the last phase of life treatment decisions differ as they often put more
Externí odkaz:
https://doaj.org/article/c2c560fcfcb5417b8e77cb9f0ab3cf12
Attenuated AMPA receptor expression allows glioblastoma cell survival in glutamate-rich environment.
Autor:
Dannis G van Vuurden, Maryam Yazdani, Ingeborg Bosma, Aart J F Broekhuizen, Tjeerd J Postma, Jan J Heimans, Paul van der Valk, Eleonora Aronica, Bakhos A Tannous, Thomas Würdinger, Gertjan J L Kaspers, Jacqueline Cloos
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5953 (2009)
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger AMPA-type glutamate receptors (AMPARs). This commonly results in Na(+) and Ca(2+)-permeability and thereby in excitotoxic cell death of the surroundin
Externí odkaz:
https://doaj.org/article/644353f91b474748a5148f3504aa7c0a
Autor:
Jantine G. Röttgering, Vera Belgers, Mathilde C.M. Kouwenhoven, Maaike Schuur, Tjeerd J. Postma, Claudia M. Nijboer, Myra E. van Linde, Philip C. de Witt Hamer, Linda Douw, Martin Klein
Publikováno v:
Heliyon, Vol 9, Iss 2, Pp e13278- (2023)
Background & aims: Glioma patients experience a multitude of symptoms that negatively affect their health-related quality of life. Symptoms vary greatly across disease phases, and the patients' stable phase might be particularly suitable for assessin
Externí odkaz:
https://doaj.org/article/fcc9aa3edf7a4b508cf2bf92ddf4817d
Autor:
Geert Kazemier, Ernest J Wouda, Merijn E de Swart, Esther Sanchez Aliaga, David P. Noske, Maaike Schuur, B. Moraal, Babette I. Kuiper, Philip C. De Witt Hamer, Tjeerd J. Postma, William P. Vandertop, Mathilde C.M. Kouwenhoven, Niels K Maliepaard, B.M. Zonderhuis, Bernard M. J. Uitdehaag, Tessa Hellingman, Cathelijne Gorter de Vries, Machteld Leembruggen-Vellinga
Publikováno v:
de Swart, M E, Kouwenhoven, M C M, Hellingman, T, Kuiper, B I, Gorter de Vries, C, Leembruggen-Vellinga, M, Maliepaard, N K, Wouda, E J, Moraal, B, Noske, D P, Postma, T J, Sanchez Aliaga, E, Uitdehaag, B M J, Vandertop, W P, Zonderhuis, B M, Kazemier, G, de Witt Hamer, P C & Schuur, M 2021, ' A multidisciplinary neuro-oncological triage panel reduces the time to referral and treatment for patients with a brain tumor ', Neuro-Oncology Practice, vol. 8, no. 5, pp. 559-568 . https://doi.org/10.1093/nop/npab040
Neuro-oncology practice, 8(5), 559-568. Oxford University Press
Neuro-Oncology Practice, 8(5), 559-568. Oxford University Press
Neuro-Oncology Practice
Neuro-oncology practice, 8(5), 559-568. Oxford University Press
Neuro-Oncology Practice, 8(5), 559-568. Oxford University Press
Neuro-Oncology Practice
BackgroundRegional collaboration and appropriate referral management are crucial in neuro-oncological care. Lack of electronic access to medical records across health care organizations impedes interhospital consultation and may lead to incomplete an
Autor:
Emilie Le Rhun, Patrick Devos, Sebastian Winklhofer, Hafida Lmalen, Dieta Brandsma, Priya Kumthekar, Antonella Castellano, Annette Compter, Frederic Dhermain, Enrico Franceschi, Peter Forsyth, Julia Furtner, Norbert Galldiks, Jaime Gallego Perez-Larraya, Jens Gempt, Elke Hattingen, Johann Martin Hempel, Slavka Lukacova, Giuseppe Minniti, Barbara O’Brien, Tjeerd J Postma, Patrick Roth, Roberta Rudà, Niklas Schaefer, Nils O Schmidt, Tom J Snijders, Steffi Thust, Martin van den Bent, Anouk van der Hoorn, Guillaume Vogin, Marion Smits, Joerg-Christian Tonn, Kurt Jaeckle, Matthias Preusser, Michael Glantz, Patrick Wen, Martin Bendzsus, Michael Weller
Publikováno v:
WFNOS 2022 Abstract Book.
Autor:
Roberta Rudà, Anouk van den Hoorn, Tom A. B. Snijders, Nils Ole Schmidt, Giuseppe Minniti, Hafida Lmalem, Priya Kumthekar, Barbara O’Brien, Tjeerd J. Postma, Patrick Y. Wen, Niklas Schäfer, Jaime Gállego Pérez-Larraya, Martin Bendszus, Enrico Franceschi, Johann Martin Hempel, Matthias Preusser, Jörg-Christian Tonn, Michael Glantz, Emilie Le Rhun, Patrick Devos, Guillaume Vogin, Antonella Castellano, Annette Compter, Steffi Thust, Julia Furtner, Jens Gempt, Martin J. van den Bent, Frédéric Dhermain, Dieta Brandsma, Marion Smits, Slavka Lukacova, Sebastian Winklhofer, Patrick Roth, Elke Hattingen, Kurt A. Jaeckle, Michael Weller, Norbert Galldiks, Peter A. Forsyth
Publikováno v:
Neuro Oncol
BACKGROUND Validation of the 2016 LANO MRI scorecard for leptomeningeal metastasis failed for multiple reasons. The objective of this joint EORTC Brain Tumor Group and RANO effort was to validate the feasibility of the revised MRI scorecard for asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba17c732152c294c54094e9749d9a69
https://europepmc.org/articles/PMC8598888/
https://europepmc.org/articles/PMC8598888/
Autor:
M Schuur, Mathilde C.M. Kouwenhoven, L de Glopper, F E L van den Elzen, M. E. van Linde, M Sintemaartensdijk, A N van der Vegt, N Grun, Tjeerd J. Postma, J Osinga
Publikováno v:
Neuro Oncol
BACKGROUND Glioblastoma has an infiltrative growth pattern that makes complete resection of the tumor virtually impossible. Sooner or later the tumor progresses, even after aggressive treatment with maximal safe resection, radiotherapy and/or chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26585b03551878dc0e5caee325af119
https://europepmc.org/articles/PMC8427454/
https://europepmc.org/articles/PMC8427454/
Autor:
J Osinga, Tjeerd J. Postma, P. de Haan, A N van der Vegt, M Schuur, William P. Vandertop, Mathilde C.M. Kouwenhoven, M. E. van Linde, N Grun, R.E. de Vries
Publikováno v:
Neuro-Oncology, 23, 47-47. Oxford University Press
Van der Vegt, A N, de Vries, R, Osinga, J, Grun, N, Postma, T J, de Haan, P F, van Linde, M E, Vandertop, W P, Schuur, M & Kouwenhoven, M C M 2021, ' P14.51 Can patients with a suspected high-grade glioma receive tumor treatment during pregnancy safely? ', Neuro-Oncology, vol. 23, pp. 47-47 .
Van der Vegt, A N, de Vries, R, Osinga, J, Grun, N, Postma, T J, de Haan, P F, van Linde, M E, Vandertop, W P, Schuur, M & Kouwenhoven, M C M 2021, ' P14.51 Can patients with a suspected high-grade glioma receive tumor treatment during pregnancy safely? ', Neuro-Oncology, vol. 23, pp. 47-47 .
BACKGROUND Diagnosis of a glioma during pregnancy has ethical and medical dilemmas; treatment of the mother may harm the unborn child, but a too conservative approach towards tumor treatment can compromise the survival of the mother. In patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1bf3a26d5ec6614a68470f20582492d
https://research.vumc.nl/en/publications/c9374680-8384-407c-b8a0-d7f16a896a31
https://research.vumc.nl/en/publications/c9374680-8384-407c-b8a0-d7f16a896a31
Autor:
J. G. Rottgering, P. C. de Witt Hamer, Martin Klein, M Schuur, Linda Douw, Mathilde C.M. Kouwenhoven, M. E. van Linde, V. Belgers, C. M. Nijboer, Tjeerd J. Postma
Publikováno v:
Neuro-Oncology. Oxford University Press
Röttgering, JG, Belgers, V, Kouwenhoven, MCM, Schuur, M, Postma, TJ, Nijboer, C M, van Linde, ME, Versélewel de Witt Hamer, PC, Douw, L & Klein, M 2021, ' P12.02 Symptoms of patients with diffuse glioma during stable disease as a potential target for treatment ', Neuro-Oncology . https://doi.org/10.1093/neuonc/noab180.104
Röttgering, JG, Belgers, V, Kouwenhoven, MCM, Schuur, M, Postma, TJ, Nijboer, C M, van Linde, ME, Versélewel de Witt Hamer, PC, Douw, L & Klein, M 2021, ' P12.02 Symptoms of patients with diffuse glioma during stable disease as a potential target for treatment ', Neuro-Oncology . https://doi.org/10.1093/neuonc/noab180.104
BACKGROUND Patients with diffuse glioma experience many tumor- and treatment-related symptoms, including fatigue, cognitive deficits, and anxiety. It remains unclear how the frequency and burden of these symptoms change over time and specifically whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a50c44fa32fb1207ae7b488de4c889
https://research.vumc.nl/en/publications/fa74b0ab-3f99-4075-8327-01eea9d779fa
https://research.vumc.nl/en/publications/fa74b0ab-3f99-4075-8327-01eea9d779fa
Autor:
M Schuur, Joost J.C. Verhoeff, J.F. de Haan, Mathilde C.M. Kouwenhoven, Tjeerd J. Postma, C A den Otter, P. C. de Witt Hamer, N Grun, Birgit I. Lissenberg-Witte, M Sintemaartensdijk, F.Y.F.L. De Vos, F E L van den Elzen, Anna M.E. Bruynzeel, J Osinga, A N van der Vegt, Joost L M Jongen, M. E. van Linde
Publikováno v:
Neuro Oncol
BACKGROUND Besides early tumour progression, standard first-line radiation with concurrent and adjuvant temozolomide in de novo glioblastoma patients is abrogated frequently by severe haematological toxicity. This leads to treatment delays with unkno